These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37365560)

  • 1. SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway.
    Xue Z; Wang J; Wang Z; Liu J; Zhao J; Liu X; Zhang Y; Liu G; Zhao Z; Li W; Zhang Q; Li X; Huang B; Wang X
    BMC Cancer; 2023 Jun; 23(1):589. PubMed ID: 37365560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway.
    Ni H; Ji D; Huang Z; Li J
    Arch Biochem Biophys; 2020 Nov; 695():108628. PubMed ID: 33049294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GALNT12 is associated with the malignancy of glioma and promotes glioblastoma multiforme in vitro by activating Akt signaling.
    Zheng Y; Liang M; Wang B; Kang L; Yuan Y; Mao Y; Wang S
    Biochem Biophys Res Commun; 2022 Jun; 610():99-106. PubMed ID: 35461073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCF1/CXCL12/CXCR4 Enhances Glioblastoma Cell Proliferation, Migration, and Invasion by Activating the PI3K/AKT Signal Pathway.
    Yin X; Xia K; Peng S; Tan B; Huang Y; Wang M; He M
    Dev Neurosci; 2024; 46(3):210-220. PubMed ID: 37757768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways.
    Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G
    Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SAMMSON Knockdown Inhibits the Malignancy of Glioblastoma Cells by Inactivation of the PI3K/Akt Pathway.
    Ni H; Wang K; Xie P; Zuo J; Liu W; Liu C
    Cell Mol Neurobiol; 2021 Jan; 41(1):79-90. PubMed ID: 32236901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway.
    Cheng Y; Xie P
    J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
    Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
    Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
    Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma.
    Chen J; Zhang J; Hong L; Zhou Y
    Cancer Biomark; 2019; 24(3):343-350. PubMed ID: 30829611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
    Fan HW; Ni Q; Fan YN; Ma ZX; Li YB
    Cell Prolif; 2019 May; 52(3):e12584. PubMed ID: 30834619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12-induced upregulation of FOXM1 expression promotes human glioblastoma cell invasion.
    Wang S; Zhang S; Li J; Xu X; Weng Y; Zheng M; Ouyang L; Li F
    Biochem Biophys Res Commun; 2014 Apr; 447(1):1-6. PubMed ID: 24561124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines.
    Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F
    J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated ETV6 Expression in Glioma Promotes an Aggressive In Vitro Phenotype Associated with Shorter Patient Survival.
    Xiong Z; Wu S; Li FJ; Luo C; Jin QY; Connolly ID; Hayden Gephart M; You L
    Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292767
    [No Abstract]   [Full Text] [Related]  

  • 20. HNF1A induces glioblastoma by upregulating EPS8 and activating PI3K/AKT signaling pathway.
    Yang G; Su F; Han BX; Su HX; Guo CH; Yu SH; Guan QL; Hou XM
    Biochem Pharmacol; 2024 May; 223():116133. PubMed ID: 38494066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.